China-developed first nasal spray COVID-19 vaccine approved for clinical trials

China has approved the trials of its first nasal spray vaccine against coronavirus that has claimed over 904,000 lives and infected more than 27 million people globally. The only nasal spray vaccine is expected to start phase I clinical trials in November, and it is recruiting 100 volunteers.

from IndiaTV India: Google News Feed https://ift.tt/33vbNxh
via